A higher prevalence of germline mutations in BAP1 (not identified in our patients) and POT1 was also reported in a recent study by Pastorino and colleagues who identified seven carriers (2.6%) of mutations in each of these two genes among 273 Italian melanoma patients [45]. This evidence concerns the gene BAP1 and melanoma.